Background: The present study evaluated the effectiveness and safety of clozapine versus "high-dose" olanzapine in treatment-refractory adolescents with schizophrenia.

Methods: Children, ages 10-18 years, who met DSM-IV criteria for schizophrenia and who were resistant or intolerant to at least two antipsychotic drugs were randomized to receive 12 weeks of double-blind flexibly dosed treatment with clozapine (n = 18) or "high-dose" olanzapine (up to 30 mg/day) (n = 21). The primary efficacy measure was response (improvement), defined as a decrease of 30% or more in total Brief Psychiatric Rating Scale score from baseline and a Clinical Global Impression Scale improvement rating of "1" (very much improved) or "2" (much improved).

Results: Significantly more clozapine-treated adolescents met response criteria (66%) compared with olanzapine-treated subjects (33%). Clozapine was superior to olanzapine in terms of reduction of the psychosis cluster scores and negative symptoms from baseline to end point. However, both treatments were associated with significant weight-gain and related metabolic abnormalities.

Conclusions: This double-blind randomized comparison of two second-generation antipsychotic drugs for treatment-refractory adolescents with schizophrenia supports clozapine as the agent of choice. The development of interventions to limit weight gain and metabolic side effects are needed to enhance the risk-benefit profile for both study treatments.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2007.04.043DOI Listing

Publication Analysis

Top Keywords

"high-dose" olanzapine
12
clozapine "high-dose"
8
treatment-refractory adolescents
8
antipsychotic drugs
8
clozapine
5
olanzapine
4
olanzapine refractory
4
refractory early-onset
4
early-onset schizophrenia
4
schizophrenia 12-week
4

Similar Publications

Introduction: Olanzapine, an atypical antipsychotic, is widely used for treating psychiatric conditions such as schizophrenia and bipolar disorder. Accidental overdose in children is rare but can lead to severe clinical effects. This case report discusses the management of a 5-year-old male who accidently ingested 180 mg of olanzapine, the highest reported dose in a child around 5 year.

View Article and Find Full Text PDF

Background: Antipsychotic drugs (APDs) are used for treating mental illnesses and are also used by cancer patients. This study aimed to evaluate APD use in adult cancer patients who received radiotherapy (RT) in South Korea and assess the effects of APD use during RT on survival.

Methods: This retrospective cohort study utilized the National Health Insurance Service database database of Korea.

View Article and Find Full Text PDF
Article Synopsis
  • The case study describes a 15-year-old male who exhibited atypical symptoms of obsessive-compulsive disorder (OCD) leading to severe medical issues, exacerbated by pandemic-related restrictions on team sports that drove him to compulsive exercise and food restriction.* -
  • The individual experienced serious health complications such as bradycardia, hypothermia, and hypoglycemia due to malnutrition, resulting in a significant weight loss to 85.8% of his ideal body weight and necessitating intensive care for exercise-induced rhabdomyolysis.* -
  • Treatment involved a combination of psychotropic medications and cognitive-behavioral therapy, emphasizing the life-threatening risks of excessive exercise and malnutrition, as well as
View Article and Find Full Text PDF

Characterising the nature of psychiatric disorders and patterns of antipsychotic medications prescribed in a psychiatric ward in a public hospital in Tasmania.

Australas Psychiatry

September 2024

Tasmanian Centre for Mental Health Service Innovation, Tasmanian Health Service, Hobart, TAS, Australia; and School of Medicine, University of Tasmania, Hobart, TAS, Australia.

Objective: We present an evaluation of antipsychotic prescribing in an inpatient psychiatry ward in Hobart, Tasmania, to establish pattern of use, alignment with other psychiatric wards or centres and the recommendations in the Royal Australian and New Zealand College of Psychiatry Clinical Practice Guidelines, and to determine predictors of polypharmacy.

Methods: A descriptive cross-sectional survey design was used. Data from 118 patients discharged from the Royal Hobart Hospital (RHH) Mental Health Inpatient Unit between 01/02/2021 to 01/08/2021 were evaluated.

View Article and Find Full Text PDF

Introduction: This systematic review, adhering to PRISMA guidelines, aimed to evaluate the efficacy and safety of antiemetic prophylaxis in haematological patients undergoing high-dose chemotherapy as part of their hematopoietic stem cell transplantation (HSCT) conditioning regimens.

Methods: We performed a comprehensive search in PubMed, EMBASE, ClinicalTrials.gov and the Cochrane database to identify randomised controlled trials (RCTs) and systematic reviews of antiemetic prophylaxis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!